Further metabolism of 2-formylaminofluorene, a metabolite of 2-aminofluorene, in rats

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 2, 1996, Pages 330-333

  Ueda, Osamu ^a   Kitamura, Shigeyuki ^a   Tatsumi, Kiyoshi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

2 formylaminofluorene; 5 hydroxy 2 acetylaminofluorene; 5 hydroxy 2 formylaminofluorene; 7 hydroxy 2 acetylaminofluorene; 7 hydroxy 2 formylaminofluorene; In vivo metabolism

Indexed keywords

2 ACETAMIDO 5 HYDROXYFLUORENE; 2 FLUORENYLAMINE; 2 FORMYLAMINO 5 HYDROXYFLUORENE; 2 FORMYLAMINO 7 HYDROXYFLUORENE; 7 HYDROXY N 2 FLUORENYLACETAMIDE; ARYLSULFATASE; BETA GLUCURONIDASE; UNCLASSIFIED DRUG;

ACETYLATION; ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; IN VIVO STUDY; METABOLIC REGULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; REACTION ANALYSIS;

ANIMALS; CARCINOGENS; FLUORENES; MALE; RATS; RATS, WISTAR;

EID: 0029923091     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.330     Document Type: Article

References (22)

1. Weber W. W., Hein D. C., Pharmacol. Rev., 37, 25 (1985).
2. Gothoskar S. V., Benjamin T., Roller P. P., Weisburger E. K., Xenobiotica, 9, 533 (1979).
3. Baker M. H., Foster A. B., Harland S. J., Jarman M., Proceeding of the B.S.P., April 1981, p. 243.
4. Boyland E., Manson D., Biochem. J., 95, 7 (1965).
5. Boyland E., Manson D., Biochem. J., 99, 189 (1966).
6. Tatsumi K., Kitamura S., Amano H., Ueda K., Cancer Res., 49, 2059 (1989).
7. Santti R. S. S., Hopsu-Havu V. K., Biochem Pharmacol, 17, 1110 (1968).
8. Tatsumi K., Amano H., Biochem. Biophys. Res. Commun., 142, 376 (1987).
9. Okumura F., Ueda O., Kitamura S., Tatsumi K., Carcinogenesis, 16, 71 (1995).
10. Weisburger J. H., Weisburger E. K., Morris H. P., J. Natl. Cancer Inst.. 17, 345 (1956).
11. Weisburger E. K., Weisburger J. H., Adv. Cancer Res., 5, 331 (1958).
12. Cramer J. W., Miller J. A., Miller E. C., J. Biol. Chem., 235, 250 (1960).
13. Miller E. C., Miller J. A., Hartmann H. A., Cancer Res., 21, 815 (1961).
14. Miller J. A , Miller E. C., Prog. Exp. Tumor. Res., 11, 731 (1969).
15. Miller E. C., Miller J. A., Ann. N.Y. Acad. Sci., 163, 559 (1969).
16. Miller J. A., Cancer Res., 30, 559 (1970).
17. Miller E. C., Cancer Res., 38, 1479 (1978).
18. Bielschowsky F , Biochem. J., 39, 287 (1945).
19. Weisburger E. K., Weisburge J. H., J. Org. Chem., 20, 1396 (1955).
20. Prager B., Jacobson P., Schmidt P., Stern D. (eds.), Isocyclische Reihe Monoamine. Beilstein Handbuch Der Organische Chemie, 12, 611 (1929).
21. Prager B., Jacobson P., Schmidt P., Stern D. (eds.), Isocyclische Reihe Polyamine, Oxy-Amine. Beilstein Handbuch Der Organische Chemie, 13, 459 (1930).
22. Miller J. A., Cramer J. W., Miller E. C., Cancer Res., 20, 950 (1960).